B
BioMarin Pharmaceutical Inc. (BMRN)
NMS – Real vaqt narxi. Valyuta: USD
59.00
+1.65 (2.88%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
58.60
-0.40 (-0.68%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
59.00
+1.65 (2.88%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
58.60
-0.40 (-0.68%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
This stock has a consensus price target of $89.13 based on the ratings of 31 analysts. The high is $126.00 and the low is $50.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 50 | $ 89.13 | $ 126 |
| O’zgarish | -12.82% | 55.41% | 119.70% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-22 | 88.14% | Canaccord Genuity | $116 → $111 | Maintains | Buy |
| 2026-05-19 | 35.59% | B of A Securities | $85 → $80 | Maintains | Buy |
| 2026-05-19 | 27.12% | Citigroup | $75 | Initiates Coverage On | Buy |
| 2026-05-18 | -15.25% | HC Wainwright & Co. | $55 → $50 | Maintains | Neutral |
| 2026-05-11 | 16.95% | Goldman Sachs | $69 | Reinstates | Buy → Neutral |